

Ragada El-Damanawi
857 posts

@ElRagada
Consultant Nephrologist and Clinical Trialist



🔍Check Out Our Autumn Newsletter🔎 In this edition, we share a research study that gives hope to PKD patients and offer tips on how to write to your organ donor if you've had a transplant. There's also a "wee" story from a patient about their personal journey with tolvaptan. Plus, we celebrate the amazing achievements of our fundraisers who are making a BIG difference 👀👉 bit.ly/Aut24NL










Highly convincing data from @brendonneuen and SMART-C that use of GLP-1 RA neither affects the efficacy, nor the safety, of SGLT-2 I. smart-c.net/wp-content/upl… After FLOW comes the question whether SGLT-2 I affects the efficacy of GLP-1 RA.














Hot on the heels of FLOW: What are the effects of SGLT2i on clinical outcomes with and without GLP-1RA? 🧵 Over 3,000 patients receiving GLP-1RA at baseline in SGLT2i Trialists' Consortium (SMART-C) #ERA24 @ERAkidney